Real-world Profile of a Selective Peroxisome Proliferator-activated Receptor α Modulator (SPPARMα) in Japanese Patients with Renal Impairment and Dyslipidemia

OBJECTIVE: Although lowering the low-density lipoprotein cholesterol (LDL-C) levels using statins can reduce cardiovascular risk, 70% of the cardiovascular risk remains despite treatment with statins. Several studies have shown that elevated triglyceride (TG)-rich lipoprotein is the primary therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Toshinori, Miura, Takashi, Joko, Kensuke, Sunohara, Daisuke, Mochidome, Tomoaki, Kasai, Toshio, Ikeda, Uichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479210/
https://www.ncbi.nlm.nih.gov/pubmed/33776008
http://dx.doi.org/10.2169/internalmedicine.6871-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479210/
https://www.ncbi.nlm.nih.gov/pubmed/33776008
http://dx.doi.org/10.2169/internalmedicine.6871-20

Ejemplares similares